Cargando…
Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population
BACKGROUND: In epilepsy, in spite of the best possible medications and treatment protocols, approximately one-third of the patients do not respond adequately to anti-epileptic drugs. Such interindividual variations in drug response are believed to result from genetic variations in candidate genes be...
Autores principales: | Kumari, Ritu, Lakhan, Ram, Garg, R. K, Kalita, J, Misra, U. K, Mittal, Balraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125053/ https://www.ncbi.nlm.nih.gov/pubmed/21747585 http://dx.doi.org/10.4103/0971-6866.80357 |
Ejemplares similares
-
Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy
por: Lakhan, Ram, et al.
Publicado: (2011) -
Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013) -
Pharmacogenomics of cardiovascular drugs
por: Adithan, C
Publicado: (2014) -
Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022) -
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
por: Li, Jing, et al.
Publicado: (2011)